Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell ...

Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...

A leading fund manager expects more strong performance from this surging ASX 200 healthcare stock. The post Up 135% in a year ...

Researchers from the Nagoya University Graduate School of Medicine identified an enzyme, alpha-kinase 2 (ALPK2) that is ...

Researchers discovered that ALPK2, a heart-specific enzyme, may protect against HFpEF by activating TPM1 in heart muscle ...

This underscores the unmet clinical need for the development of more effective drug-radiotherapy combinations to enhance the therapeutic index of radiation therapy (RT). The RNA demethylase enzyme FTO ...

Children may have a higher risk of developing ADHD if their mothers used paracetamol – also known as acetaminophen – during ...

Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China University of Chinese Academy of Sciences, Beijing 100049, China ...

Department of Pharmaceutics, School of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, ...